3-deoxyglucose has been researched along with Diabetes Mellitus, Type 1 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Niimura, K; Niwa, T; Ohara, M; Takeda, N; Tatematsu, A; Tomiyama, S; Yoshizumi, H | 1 |
Bretzel, RG; Brownlee, M; Hammes, HP; Lin, J; Schleicher, E | 1 |
2 other study(ies) available for 3-deoxyglucose and Diabetes Mellitus, Type 1
Article | Year |
---|---|
Presence of 3-deoxyglucosone, a potent protein crosslinking intermediate of Maillard reaction, in diabetic serum.
Topics: Adult; Aged; Biomarkers; Cross-Linking Reagents; Deoxyglucose; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Gas Chromatography-Mass Spectrometry; Humans; Maillard Reaction; Male; Middle Aged; Reference Values | 1993 |
Diabetic retinopathy risk correlates with intracellular concentrations of the glycoxidation product Nepsilon-(carboxymethyl) lysine independently of glycohaemoglobin concentrations.
Topics: Adult; Deoxyglucose; Diabetes Mellitus, Type 1; Diabetic Retinopathy; Female; Glycated Hemoglobin; Glycation End Products, Advanced; Humans; Leukocyte Common Antigens; Lysine; Male; Middle Aged; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Pyruvaldehyde; Risk Factors; T-Lymphocytes | 1999 |